Skip to content

News Releases

Date Title and Summary Additional Formats
Toggle Summary MethylGene Provides Clinical Update on its MGCD290 Novel Antifungal Therapeutic Program
Phase I Data to be Presented at the 2012 IDWeek
View HTML
Toggle Summary MethylGene Presents Clinical Data on MGCD265 at The European Society For Medical Oncology (ESMO) 2012 Congress
Three Posters Provide Updates on Monotherapy, Combination Therapy and Healthy Volunteer Trials
View HTML
Toggle Summary MethylGene Announces Change of President and CEO View HTML
Toggle Summary MethylGene Presents MGCD290 Data at The 2012 Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) View HTML
Toggle Summary MethylGene to Present MGCD290 Data at The 2012 Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) View HTML
Toggle Summary MethylGene to Present at The 2012 Stifel Nicolaus Healthcare Conference View HTML
Toggle Summary MethylGene Reports Second Quarter 2012 Financial Results and Provides an Update on its Clinical Programs View HTML
Toggle Summary MethylGene to Present at the Seventh Annual JMP Securities Healthcare Conference View HTML
Toggle Summary MethylGene Announces the Appointment of Dr. Rodney Lappe to its Board of Directors View HTML
Toggle Summary MethylGene to Present at The Bloom Burton & Co. Healthcare Investor Conference View HTML